Publicaciones

  1. Llorente-González S, Hernandez M, González-Zamora J, Bilbao-Malavé V, Fernández-Robredo P, Saenz-de-Viteri M, Barrio-Barrio J, Rodríguez-Cid MJ, Donate J, Ascaso FJ, Gómez-Ramírez AM, Araiz J, Armadá F, Ruiz-Moreno Ó, Recalde S, García-Layana A; Spanish AMD group. The role of retinal fluid location in atrophy and fibrosis evolution of patients with neovascular age-related macular degeneration long-term treated in real world. Acta Ophthalmol. 2021 Jun 4. doi: 10.1111/aos.14905.
  2. Ruzafa N, Pereiro X, Fonollosa A, Araiz J, Acera A, Vecino E. Plasma Rich in Growth Factors (PRGF) Increases the Number of Retinal Müller Glia in Culture but Not the Survival of Retinal Neurons. Front Pharmacol. 2021 Mar 9;12:606275. doi: 10.3389/fphar.2021.606275. eCollection 2021.
  3. Ruzafa N, Pereiro X, Fonollosa A, Araiz J, Acera A, Vecino E. The Effect of Plasma Rich in Growth Factors on Microglial Migration, Macroglial Gliosis and Proliferation, and Neuronal Survival. Front Pharmacol. 2021 Feb 26;12:606232. doi: 10.3389/fphar.2021.606232. eCollection 2021.
  4. Pereiro X, Fernández R, Barreda-Gómez G, Ruzafa N, Acera A, Araiz J, Astigarraga E, Vecino E. Comparative lipidomic analysis of mammalian retinal ganglion cells and Müller glia in situ and in vitro using High-Resolution Imaging Mass Spectrometry. Sci Rep. 2020 Nov 18;10(1):20053. doi: 10.1038/s41598-020-77087-x.
  5. Acera A, Pereiro X, Abad-Garcia B, Rueda Y, Ruzafa N, Santiago C, Barbolla I, Duran JA, Ochoa B, Vecino E. A simple and reproducible method for quantification of human tear lipids with ultrahigh-performance liquid chromatography-mass spectrometry. Mol Vis. 2019 Dec 31;25:934-948. eCollection 2019.
  6. Ainhoa Bilbao. Colirios (III). Panorama Actual del Medicamento 2019; 43 (420): 114-120.
  7. Suárez-Barrio C, Etxebarria J, Hernáez-Moya R, Del Val-Alonso M, Rodriguez-Astigarraga M, Urkaregi A, Freire V, Morales MC, Durán JA, Vicario M, Molina I, Herrero-Vanrell R, Andollo N. Hyaluronic Acid Combined with Serum Rich in Growth Factors in Corneal Epithelial Defects. Int J Mol Sci. 2019 Apr 3;20(7):1655. doi: 10.3390/ijms20071655.
  8. Recalde JI, Duran JA, Rodriguez-Agirretxe I, Soria J, Sanchez-Tena MA, Pereiro X, Suarez T, Acera A. Changes in tear biomarker levels in keratoconus after corneal collagen crosslinking. Mol Vis. 2019 Jan 20;25:12-21.
  9. Garcia-Arumi J, Gómez-Ulla F, Amparo N, Cervera E, Fonollosa A, Arias L, Araiz J, Donate J, de Figueroa MS, Manzanas L, Crespí J, Gallego R. Efficacy and Safety of an Aflibercept Treat-and-Extend Regimen in Treatment-Naïve Patients with Macular Oedema Secondary to Central Retinal Vein Occlusion (CRVO): A Prospective 12-Month, Single-Arm, Multicentre Trial. J Ophthalmol. 2018 Oct 14;2018:8310350.
  10. Soria J, Acera A, Durán JA, Boto-de-Los-Bueis A, Del-Hierro-Zarzuelo A, González N, Reigada R, Suárez T. The analysis of human conjunctival epithelium proteome in ocular surface diseases using impression cytology and 2D-DIGE. Exp Eye Res. 2018 Feb;167:31-43.
  11. Ainhoa Bilbao. Colirios (II). Panorama Actual del Medicamento 2018; 42 (414): 602-608
  12. De Frutos-Lezaun M, Rodriguez-Agirretxe I, Eder Labairu F, Irigoyen C. Vitrectomy combined with posterior-segment Ahmed valve implant: A case series study. Saudi J Ophthalmol. 2018 Jul-Sep;32(3).
  13. Belda JI, Loscos-Arenas J, Mermoud A, Lozano E, D’Alessandro E, Rebolleda G, Rodriguez-Agirretxe I, Canut M, Rodriguez-Calvo PP; ESNOPER V-2000 Study Group. Supraciliary versus intrascleral implantation with hema implant (Esnoper V-2000) in deep sclerectomy: a multicenter randomized controlled trial. Acta Ophthalmol. 2018 May 31.
  14. Ainhoa Bilbao. Colirios (I). Panorama Actual del Medicamento 2018; 42 (414): 602-608
  15. Ruzafa N, Pereiro X, Aspichueta P, Araiz J, Vecino E. The Retina of Osteopontin deficient Mice in Aging. Mol Neurobiol. 2018 Jan;55(1):213-221
  16. Rodriguez-Agirretxe I, Garcia I, Soria J, Suarez TM, Acera A. Custom RT-qPCR-array for glaucoma filtering surgery prognosis. PLoS One. 2017 Mar 30;12(3).
  17. Rodríguez-Agirretxe I, Freire V, Muruzabal F, Orive G, Anitua E, Díez-Feijóo E, Acera A. Subconjunctival PRGF Fibrin Membrane as an Adjuvant to Nonpenetrating Deep Sclerectomy: A 2-Year Pilot Study. Ophthalmic Res. 2018;59(1):45-52.
  18. Soria J, Acera A, Merayo-LLoves J, Durán JA, González N, Rodriguez S, Bistolas N, Schumacher S, Bier FF, Peter H, Stöcklein W, Suárez T. Tear proteome analysis in ocular surface diseases using label-free LC-MS/MS and multiplexed-microarray biomarker validation. Sci Rep. 2017 Dec 12;7(1).
  19. Durán JA, Gutiérrez E, Atienza R, Piñero DP. Vector analysis of astigmatic changes and optical quality outcomes after wavefront-guided laser in situ keratomileusis using a high-resolution aberrometer. J Cataract Refract Surg. 2017 Dec;43(12):1515-1522.
  20. Etxebarria J, Sanz-Lázaro S, Hernáez-Moya R, Freire V, Durán JA, Morales MC, Andollo N. Serum from plasma rich in growth factors regenerates rabbit corneas by promoting cell proliferation, migration, differentiation, adhesion and limbal stemness. Acta Ophthalmol. 2017 Dec;95(8).
  21. Recalde JI, Acera A, Rodríguez-Agirretxe I, Sánchez-Tena MA, San-Cristóbal J, Durán JA. Ocular Surface Disease Parameters After Collagen Cross-Linking for Keratoconus. Cornea. 2017 Feb;36(2):148-152.
  22. Anitua E, Muruzabal F, de la Fuente M, Merayo J, Durán J, Orive G. Plasma Rich in Growth Factors for the Treatment of Ocular Surface Diseases. Curr Eye Res. 2016 Jul;41(7):875-82. doi: 10.3109/02713683.2015.1104362. Epub 2016 Feb 1.

Pide cita

Llámanos al

944 733 545

O escríbenos a

info@icqo.org

O, si lo prefieres, te contactamos nosotros




    HORARIO

    CONSULTAS
    L-V: 09:00 - 20:00

    URGENCIAS
    L-V: 09:00 - 13:30
    L-V: 15:00 - 19:30
    S: 10:00 - 13:30